The Cell Cryopreservation Market was valued at USD 7.2 Billion in 2022. The industry is projected to grow from USD 8.8 Billion in 2023 to USD 46.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 23.00% during the forecast period (2024 - 2032). Expanding activities in biobanking, advancements in cellular treatments, and Increasing research on stem cells are the primary drivers propelling the market's growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The growing adoption of automated cryopreservation systems is driving the market growth.
The efficiency and reproducibility of cryopreservation methods are increased when automated cryopreservation devices precisely control freezing and thawing procedures. This dependability is essential for preserving cell viability and performance, which fuels the need for automated systems in clinical, commercial, and research settings. Automation makes it possible to standardize cryopreservation procedures, which lowers sample variability and increases sample quality consistency. Large-scale biobanking projects, the production of cell therapies, and high-throughput research applications depend on this standardization, which propels the uptake of automated systems. Compared to manual procedures, automated cryopreservation systems offer great throughput and scalability since they can handle numerous samples simultaneously. This feature boosts productivity and efficiency and is especially useful for biobanks, cell production plants, and research labs handling huge samples.
Additionally, biological samples can be preserved instantly at the bedside or in remote locations thanks to point-of-care cryopreservation technologies, eliminating the need to transport them to centralized cryopreservation facilities. This capability is fueled by the need for point-of-care solutions, which is especially advantageous in resource-constrained environments, field research, and emergency medical scenarios. Point-of-care technologies make cryopreservation capabilities more accessible and convenient for patients, researchers, and healthcare professionals by decentralizing these functions. This accessibility promotes market growth and democratizes access to cryopreservation technology by extending the reach of cryopreservation services to underserved areas, rural populations, and areas with weak healthcare infrastructure.
Rare cell types are essential to cell therapy and regenerative medicine applications, including stem cells, progenitor cells, and immune cells. The creation and commercialization of cell-based therapeutics depend on cryopreservation techniques that maintain the functionality and regenerative capacity of rare cell populations, which increases demand for cryopreservation products in the biopharmaceutical sector. These resources are essential for gathering, preserving, and disseminating rare cell samples for scientific and medical purposes. The success of biobanking projects depends on cryopreservation methods that guarantee the long-term stability and survival of rare cell populations, which stimulates investment in cryopreservation services and infrastructure.
Biobanks play a crucial role in the storage and preservation of biological samples, such as tissues and cells, for research and therapeutic applications. Economically developed nations had at least 11 biobanks per million persons in 2022, according to the National Library of Medicine, thus driving the Cell Cryopreservation market revenue.
Based on Type, the Cell Cryopreservation market segmentation includes cell freezing media, equipment, consumables, and others. In 2023, the consumables segment dominated the market. The materials utilized in the cryopreservation process, such as cryovials, cryobags, and labels, are referred to as consumables in the cell cryopreservation market. These supplies are made to ensure that cells are frozen and thawed securely and effectively. Consumables are evolving to meet sustainability issues in the cryopreservation workflow. Specialized containers with enhanced insulating qualities are becoming more popular, and eco-friendly single-use solutions are being developed.
The cell-freezing media category is anticipated to be the fastest growing. Formulations found in cell freezing mediums in the cell cryopreservation industry protect cells during the freezing process. Cryoprotectants and other chemicals are usually used in these mediums to reduce the production of ice crystals and harm cells.
Based on application, the Cell Cryopreservation market segmentation includes stem cells, oocyte cells, sperm cells, and others. The stem cells category leads the market. Cell cryopreservation plays a major role in stem cell applications by enabling the preservation, storage, and transportation of stem cells without causing cellular or genetic alterations. Stem cells can replace diseased or damaged bodily cells as a corrective therapy. Regenerative medicine is thus centered on harnessing this potential to provide novel treatments for various diseases, including neurological problems, diabetes, and heart disease.
During the projection period, the sperm cells segment of the cell cryopreservation market is anticipated to grow at the fastest rate. Cell cryopreservation is essential for the preservation of sperm cells, which are mostly used in reproductive medicine. The current market trend centers on improving sperm cell cryopreservation methods, considering DNA integrity and motility. This is in line with the growing need for assisted reproductive technologies, which provide ways to preserve fertility and support a range of reproductive procedures.
Figure 1: Cell Cryopreservation Market, by Application, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on End Users, the Cell Cryopreservation market segment includes pharmaceutical and biotechnology companies, research institutes, biobanks, IVF clinics, and others. The IVF clinics category leads the market. The Society for Assisted Reproductive Technology reports that 12,438 healthy women stored their eggs in 2020. In 2020, 72.76% more women will freeze their eggs than in 2016. Reliable and efficient cryopreservation techniques are in greater demand as more women decide to use egg-freezing cycles to guarantee the long-term viability of frozen eggs. The cell cryopreservation industry is growing due to the increased need for advanced infrastructure and technology.
The biobanks segment of the cell cryopreservation market is predicted to develop at the quickest rate over the projected period because keeping various cell types for scientific and medicinal purposes is a critical function of biobanks. Automated cryopreservation systems are becoming popular in biobanking to facilitate large-scale storage projects by streamlining and standardizing cell storage. As the need for well-preserved cell samples in various research fields grows, this trend helps solve the difficulties associated with manual operations.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American cell cryopreservation market will dominate this market, owing to the cell cryopreservation market in North America, which is distinguished by a focus on technological innovation and a high level of research into cryopreservation techniques. The region is experiencing a rise in demand for cryoprotectants and advanced freezing procedures because of the growing popularity of personalized medicine and a strong biomedical research sector. The swift advancement of cryopreservation technology in North America can be attributed to the strategic partnerships between academic institutes and industrial companies.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Figure 2: Cell Cryopreservation Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Cell Cryopreservation market accounts for the second-largest market share. The market for cell cryopreservation in Europe reflects the region's progressive nature, with a significant focus on environmentally friendly methods. Research collaborations and investments are increasing in the region, leading to breakthroughs in cryopreservation technology. A growing acceptance of serum-free cryopreservation techniques and strict adherence to regulatory requirements characterize Europe's approach. The market is distinguished by its dedication to moral and superior cell preservation techniques, consistent with the area's emphasis on expanding biological sciences. Further, the German Cell Cryopreservation market held the largest market share, and the UK Cell Cryopreservation market was the fastest-growing market in the European region.
The Asia-Pacific Cell Cryopreservation Market is expected to grow at the fastest CAGR from 2024 to 2032. The cell cryopreservation market in Asia-Pacific is exhibiting dynamic trends, with a noticeable emphasis on expanding biobanking activities and the growing influence of regenerative medicine. Growing awareness of stem cell applications and a thriving healthcare sector are driving demand for cryopreservation technologies in growing economies in the region. The adoption of automated cryopreservation systems is on the rise throughout Asia, demonstrating a forward-thinking approach to technological integration in cell preservation. Moreover, China’s Cell Cryopreservation market held the largest market share, and the Indian Cell Cryopreservation market was the fastest-growing market in the Asia-Pacific region.
Cell Cryopreservation Key Market Players & Competitive Insights
The Cell Cryopreservation market will continue to grow as major companies in the industry make significant R&D investments to extend their Type ranges. Significant market developments include new Type releases, contractual agreements, mergers and acquisitions, greater investments, and cooperation with other organizations. Market participants also engage in various strategic actions to broaden their footprint. The Cell Cryopreservation sector must provide affordable Types to grow and thrive in a more cutthroat and dynamic market.
Local manufacturing to lower operating costs is one of the key strategies manufacturers use in the Cell Cryopreservation market to benefit consumers and grow the market sector. Some of the biggest medical benefits in recent years have come from the Cell Cryopreservation sector. Major players in the Cell Cryopreservation market, including Thermo Fisher Scientific Inc., VWR International LLC, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare Life Sciences, BioLife Solutions Inc., Avantor Inc., Biocision LLC, Cesca Therapeutics Inc., Chart Industries Inc., Custom Biogenic Systems Inc., Worthington Industries Inc., Hamilton Company, Becton, Dickinson and Company, Brooks Automation Inc., ZENOAQ RESOURCE CO. LTD., and Aivita Biomedical, and others are attempting to increase market demand by investing in research and development operations.
A life sciences business called Biolife Solutions Inc. (BioLife Solutions) creates and produces instruments for bioproduction. The company sells items related to cell processing, such as cryogenic vials, human platelet lysate media, automated fill equipment for cell processing, and biopreservation media. It provides cryogenic freezers and accessories, automated thawing equipment, ultra-low temperature freezers, and thawing systems. BioLife Solutions also offers cold chain and storage solutions, including cloud-connected shipping containers and biological and pharmaceutical materials storage. The company sells its goods under several brands, including HypoThermosol, ThawSTAR, Nliven PR, Nliven PR, and Stemulate. Leading provider of equipment and services for cell and gene therapy bioproduction, BioLife Solutions, Inc., stated in May 2021 that it had completed the previously disclosed acquisition of Stirling Ultracold, a privately held producer of mechanical freezers with ultra-low temperatures (ULTs). About 100 energy-efficient ULT mechanical freezers will be supplied by Stirling to help customers with their cold chain capabilities for biologics and cutting-edge modalities.
Millions of people are impacted daily by their sophisticated technology, sophisticated analytics, and artificial intelligence. Leading innovator in digital solutions and medical technology worldwide, GE HealthCare uses its Edison intelligence platform to power intelligent devices, data analytics, apps, and services that help physicians make better decisions more quickly. The company, which employs about 50,000 people worldwide and has over a century of experience in the healthcare sector, is at the hub of an ecosystem that aims to digitize healthcare, advance precision health, increase productivity, and enhance outcomes for patients, providers, health systems, and researchers worldwide. They strive to build a world where healthcare has no bounds and promote a culture of respect, openness, integrity, and diversity.
Key Companies in the Cell Cryopreservation market include
Cell Cryopreservation Industry Developments
June 2023: The biopharma industry and BioLife Solutions, Inc. announced the launch of a new, large-capacity controlled-rate freezer (CRF) to expand their line of CRF products, which now come in three different shape factors. The IntelliRate i67C tabletop freezer fulfills a vital customer need for higher volume production of cell therapies.
October 2022: The management teams of Pluristyx, panCELLa, and Implant Therapeutics are excited to announce their upcoming corporate merger, contingent upon shareholder approval. The combined business will integrate complementary portfolios to offer end-to-end customer support and enhance access to various induced pluripotent stem cell (iPSC)- related products and services. By combining the technological and service offerings, patients will receive ground-breaking cell therapies much faster.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 7.2 Billion |
| Market Size 2023 | USD 8.8 Billion |
| Market Size 2032 | USD 46.3 Billion |
| Compound Annual Growth Rate (CAGR) | 23.00% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea |
| Key Companies Profiled | Thermo Fisher Scientific Inc., VWR International LLC, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare Life Sciences, BioLife Solutions Inc., Avantor Inc., Biocision LLC, Cesca Therapeutics Inc., Chart Industries Inc., Custom Biogenic Systems Inc., Worthington Industries Inc., Hamilton Company, Becton, Dickinson and Company, Brooks Automation Inc., ZENOAQ RESOURCE CO. LTD., and Aivita Biomedical |
| Key Market Opportunities | · Innovations in freezing technologies and cryoprotectants and integration with emerging technologies |
| Key Market Dynamics | · Expanding activities in biobanking adv, advancements in cellular treatments, and Increasing research on stem cells |
Frequently Asked Questions (FAQ) :
The Cell Cryopreservation market size was valued at USD 8.8 Billion in 2023.
The market is projected to grow at a CAGR of 23.00% during the forecast period, 2024-2032.
North America had the largest share of the market.
The key players in the market are Thermo Fisher Scientific Inc., VWR International LLC, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare Life Sciences, BioLife Solutions Inc., Avantor Inc., Biocision LLC, Cesca Therapeutics Inc., Chart Industries Inc., Custom Biogenic Systems Inc., Worthington Industries Inc., Hamilton Company, Becton, Dickinson and Company, Brooks Automation Inc., ZENOAQ RESOURCE CO. LTD., and Aivita Biomedical, among others.
The Consumables category dominated the market in 2023.
Stem Cells had the largest share of the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
